Literature DB >> 21606262

Hepatic steatosis in morbidly obese patients undergoing gastric bypass surgery: assessment with open-system 1H-MR spectroscopy.

Jochem R van Werven1, Tim C M A Schreuder, Edo O Aarts, Aart J Nederveen, Jos W R Meijer, Frits J Berends, Ignace M C Janssen, Chris J Mulder, Peter L M Jansen, Jaap Stoker.   

Abstract

OBJECTIVE: The purpose of this study was to assess, with histopathologic control, the use of open-system 1-T (1)H MR spectroscopy for the evaluation of hepatic steatosis in morbidly obese patients undergoing gastric bypass surgery. SUBJECTS AND METHODS: Patients underwent (1)H MR spectroscopy (MRS) for the assessment of steatosis before and 3 months after surgery. Liver biopsy was performed during surgery. Hepatic steatosis was expressed as the ratio of fat peak area to cumulative water and fat peak areas. Histopathologic percentage of steatosis was graded as none (0-5%), mild (5-33%), moderate (33-66%), or severe (> 66%). The accuracy of (1)H-MRS and Spearman correlation coefficient were calculated. Differences between groups were assessed with the Wilcoxon signed rank and Mann-Whitney tests.
RESULTS: The study included 38 patients (median age, 45.5 years; median body mass index, 47.7). Before surgery, median steatosis measured with (1)H-MRS was 5.8%. The accuracy of (1)H-MRS was 89% (32/36), and the (1)H-MRS findings correlated with the histopathologic assessment of steatosis (r = 0.85, p < 0.001). With (1)H-MRS, no steatosis was discriminated from mild steatosis (p = 0.011), mild was discriminated from moderate steatosis (p < 0.001), and moderate was discriminated from severe steatosis (p = 0.021). Three months after surgery, steatosis had decreased to 3.1% (p < 0.001). The prevalence of hepatic steatosis measured with (1)H-MRS decreased from 53% to 32%.
CONCLUSION: In the care of morbidly obese patients undergoing assessment of hepatic steatosis and changes in steatosis after gastric bypass surgery, (1)H-MRS with an open 1-T MRI system is feasible. Measurements of hepatic fat with (1)H-MRS are accurate and correlate with clinical and histopathologic results.

Entities:  

Mesh:

Year:  2011        PMID: 21606262     DOI: 10.2214/AJR.10.5215

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  5 in total

1.  Detection of non-alcoholic steatohepatitis in patients with morbid obesity before bariatric surgery: preliminary evaluation with acoustic radiation force impulse imaging.

Authors:  F Guzmán-Aroca; M D Frutos-Bernal; A Bas; J A Luján-Mompeán; M Reus; Juan de Dios Berná-Serna; P Parrilla
Journal:  Eur Radiol       Date:  2012-06-01       Impact factor: 5.315

2.  Liver surface nodularity on non-contrast MRI identifies advanced fibrosis in patients with NAFLD.

Authors:  Marco Dioguardi Burgio; Riccardo Sartoris; Aurélie Beaufrere; Jules Grégory; Boris Guiu; Chloé Guillot; Pierre-Emmanuel Rautou; Laurent Castera; Mohamed Bouattour; Valérie Paradis; Valérie Vilgrain; Maxime Ronot
Journal:  Eur Radiol       Date:  2021-09-17       Impact factor: 7.034

3.  Associations of Visceral, Subcutaneous, Epicardial, and Liver Fat with Metabolic Disorders up to 14 Years After Weight Loss Surgery.

Authors:  Steven C Hunt; Lance E Davidson; Ted D Adams; Lauren Ranson; Rodrick D McKinlay; Steven C Simper; Sheldon E Litwin
Journal:  Metab Syndr Relat Disord       Date:  2020-11-02       Impact factor: 1.894

4.  Nonalcoholic Fatty liver disease, diabetes mellitus and cardiovascular disease: newer data.

Authors:  A N Mavrogiannaki; I N Migdalis
Journal:  Int J Endocrinol       Date:  2013-04-03       Impact factor: 3.257

5.  Circulating sCD36 is associated with unhealthy fat distribution and elevated circulating triglycerides in morbidly obese individuals.

Authors:  L Knøsgaard; S B Thomsen; M Støckel; H Vestergaard; A Handberg
Journal:  Nutr Diabetes       Date:  2014-04-07       Impact factor: 5.097

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.